TandemAI: Valuation, Funding & Investors
TandemAI is transforming drug discovery by integrating generative AI, physics-based modeling (molecular dynamics and quantum mechanics), an AI-powered, next generation SaaS platform, TandemViz™, and large-scale chemistry and biology labs. This computation-first approach covers the entire drug development process, from target prediction to clinical candidate determination, significantly boosting efficiency and success rates for global pharmaceutical organizations.
Leadership & Board
- Current Number of Employees
- 52
- Current LinkedIn Followers
- 6,138
Latest Estimated Valuation
- Total Amount Raised
- $22M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $22M
- Latest Funding Round
- Series A
Company Momentum Positive
TandemAI LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
TandemAI had 52 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
TandemAI had 6,138 followers as of October 26, 2026. The number of followers increased by 136 (2.27%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 14, 2025 | Series A | $22.00M | ― |
Similar Companies
A snapshot of private companies similar to TandemAI, helping you discover and navigate related company profiles.
Related News and Analysis
